Thrombosis: all 1,528 studies

Page 4 of 16. Open to participants first (240), then studies with results posted, then the rest; newest registration first within each.

• A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring AnticoagulationCompletedNCT02981472Phase 2Results posted
• Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose HeparinCompletedNCT02970032Early Phase 1Results posted
• A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)CompletedNCT02913326Phase 3Results posted
• Apixaban Versus Warfarin for the Management of Post-operative Atrial FibrillationCompletedNCT02889562Phase 2/3Results posted
• Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or SurgeryTerminatedNCT02881554Not applicableResults posted
• Tranexamic Acid and Blood Clots in Knee SurgeryCompletedNCT02867163Results posted
• Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan ProcedureCompletedNCT02846532Phase 3Results posted
• Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)CompletedNCT02833948Phase 3Results posted
• Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)CompletedNCT02798471Phase 3Results posted
• A Different Approach to Preventing ThrombosisCompletedNCT02774265Phase 3Results posted
• Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in CancerCompletedNCT02744092Not applicableResults posted
• Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"CompletedNCT02671461Phase 2Results posted
• Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous ThromboembolismCompletedNCT02585713Phase 3Results posted
• Rivaroxaban for Treatment in Venous or Arterial Thrombosis in NeonatesCompletedNCT02564718Phase 1/2Results posted
• XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed ThrombolysisTerminatedNCT02506985Phase 4Results posted
• Inflammation and Thrombosis in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement (TAVR)CompletedNCT02486367Phase 4Results posted
• Enoxaparin Metabolism in Reconstructive Surgery PatientsCompletedNCT02411292Phase 2Results posted
• Education Bundle to Decrease Patient Refusal of VTE ProphylaxisCompletedNCT02402881Not applicableResults posted
• Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary EmbolismCompletedNCT02396758Phase 4Results posted
• Evaluation of the Technical Success of IVUS Guided VCF Placement Using the LUMIFI™ With Crux® VCF SystemTerminatedNCT02394912Not applicableResults posted
• Hemodialysis Access Surveillance Evaluation StudyCompletedNCT02376361Not applicableResults posted
• A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic SurgeriesCompletedNCT02368314Phase 3Results posted
• rtPA in in the Prevention of CVAD-Associated Thrombosis and Infection in Pediatric Patients With Short Bowel SyndromeCompletedNCT02355743Phase 4Results posted
• EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous ThrombosisCompletedNCT02309411Phase 2Results posted
• Heart and Hands Study II: A Retrospective Data Collection & Analysis ProjectCompletedNCT02307318Phase 1/2Results posted
• Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) StudyCompletedNCT02303431Phase 1Results posted
• Educating Nurses About Venous Thromboembolism (VTE) PreventionCompletedNCT02301793Not applicableResults posted
• The Angel® Catheter Pivotal Clinical TrialCompletedNCT02186223Not applicableResults posted
• Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular SystemCompletedNCT02159521Phase 4Results posted
• Role of a Novel Exercise Program to Prevent Post-thrombotic SyndromeCompletedNCT02148029Not applicableResults posted
• Bioavailability of Apixaban Crushed TabletCompletedNCT02101112Phase 1Results posted
• Cancer Venous Thromboembolism (VTE)CompletedNCT02073682Phase 3Results posted
• Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)CompletedNCT02064439Phase 3Results posted
• Ticagrelor Antiplatelet Therapy to Reduce Graft Events and ThrombosisCompletedNCT02053909Phase 4Results posted
• Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical ProceduresCompletedNCT02037607Results posted
• Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related ThrombosisCompletedNCT01999179Not applicableResults posted
• The SENTRY Clinical StudyCompletedNCT01975090Not applicableResults posted
• Registry on WATCHMAN Outcomes in Real-Life UtilizationCompletedNCT01972282Results posted
• Pharmacogenomics of Antiplatelet Response - II (PARes-II)CompletedNCT01894555Phase 4Results posted
• XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm StudyCompletedNCT01894152Results posted
• Hormones Inflammation and ThrombosisTerminatedNCT01875185Phase 4Results posted
• Angel® Catheter Early Feasibility Clinical StudyTerminatedNCT01847196Not applicableResults posted
• Effect of Low Dose Corticosteroids on Perioperative Markers of Thrombosis and Fibrinolysis in Total Knee ArthroplastyCompletedNCT01815918Phase 4Results posted
• Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive PatientsTerminatedNCT01784523Phase 3Results posted
• Comparison of Different Intermittent Pneumatic Compression Devices for Deep Vein ThrombosisCompletedNCT01779648Not applicableResults posted
• Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day EnoxaparinCompletedNCT01729559Phase 4Results posted
• Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial AppendageCompletedNCT01721447Phase 4Results posted
• Oral Rivaroxaban in Children With Venous ThrombosisCompletedNCT01684423Phase 2Results posted
• SCD Use to Prevent Deep Venous Thrombosis (DVT) in Patients With PICC LinesTerminatedNCT01670188Not applicableResults posted
• A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein ThrombosisCompletedNCT01662908Phase 2Results posted
• Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)TerminatedNCT01612884Phase 4Results posted
• Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After SurgeryCompletedNCT01608906Not applicableResults posted
• PREvention of VENous Thromboembolism In Hemorrhagic Stroke PatientsTerminatedNCT01573169Phase 3Results posted
• Prasugrel for Prevention of Early Saphenous Vein Graft ThrombosisCompletedNCT01560780Phase 3Results posted
• Switching Study From Warfarin to RivaroxabanCompletedNCT01507051Phase 1Results posted
• Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus FondaparinuxCompletedNCT01499953Phase 3Results posted
• The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and StenosesTerminatedNCT01406795Not applicableResults posted
• Safety Study of the Angel™ Catheter in Subjects With Risk of Pulmonary EmbolismCompletedNCT01403090Phase 1Results posted
• Compression Treatment Effects on Complications and Healing of Achilles Tendon RuptureCompletedNCT01317160Not applicableResults posted
• Study Of Lybrel In Relation To Venous ThromboembolismCompletedNCT01297348Results posted
• XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm StudyCompletedNCT01249027Results posted
• Vasculaire Compression System Increases Flow Velocity in the Femoral VeinCompletedNCT01240330Not applicableResults posted
• Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of AspirinCompletedNCT01225562Phase 3Results posted
• EXCEL Clinical TrialCompletedNCT01205776Not applicableResults posted
• A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip ArthroplastyCompletedNCT01203098Phase 2Results posted
• A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee ArthroplastyCompletedNCT01203072Phase 2Results posted
• XIENCE V: SPIRIT WOMEN Sub-studyCompletedNCT01182428Phase 4Results posted
• XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)CompletedNCT01178268Phase 4Results posted
• Sickle Cell Trait and the Risk of Venous ThromboembolismTerminatedNCT01148940Results posted
• Pediatric Catheter-related Thrombosis Imaging StudyCompletedNCT01137578Not applicableResults posted
• XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for JapanCompletedNCT01086228Results posted
• Registry of AngioJet Use in the Peripheral Vascular SystemCompletedNCT01086215Results posted
• Hemorrhage Risk Prescribed ArixtraCompletedNCT01064362Results posted
• An Observational Study On The Safety And Tolerability Of Prolonged Thrombosis Prophylaxis With Fragmin®CompletedNCT01046903Results posted
• Personalized Medicine Interface Tool (PerMIT): Warfarin: A Trial Comparing Usual Care Warfarin Initiation to PerMIT Pharmacogenetic Guided Warfarin TherapyCompletedNCT00993200Phase 4Results posted
• Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).CompletedNCT00986154Phase 3Results posted
• Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of ThrombosisCompletedNCT00913133Phase 4Results posted
• The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese PatientsCompletedNCT00911157Phase 3Results posted
• Randomized Trial of Interventions to Improve Warfarin AdherenceCompletedNCT00904982Not applicableResults posted
• Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy.CompletedNCT00878826Phase 2/3Results posted
• Personalized Warfarin Dosing by Genomics and Computational IntelligenceTerminatedNCT00872079Not applicableResults posted
• Pilot Study for VeinoPlus to Improve Symptoms of Postthrombotic Syndrome (PTS)CompletedNCT00858130Not applicableResults posted
• A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing SurgeryCompletedNCT00843492Phase 3Results posted
• Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed ThrombolysisCompletedNCT00790335Phase 3Results posted
• A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical ProphylaxisTerminatedNCT00789399Not applicableResults posted
• A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis SyndromeTerminatedNCT00787332Phase 4Results posted
• Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 InducerCompletedNCT00786422Phase 2Results posted
• Heparin and the Reduction of Thrombosis (HART) TrialCompletedNCT00779558Not applicableResults posted
• A Prospective Observational Registry of Peripheral Use of AngioJet Rheolytic Thrombectomy With Mid-Length CathetersCompletedNCT00778336Results posted
• Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered CathetersCompletedNCT00728819Not applicableResults posted
• Evaluation of the Duration of Therapy for Thrombosis in ChildrenCompletedNCT00687882Phase 3Results posted
• Epidemiology of Thromboembolism Disease: A Cohort StudyCompletedNCT00670540Results posted
• Evaluation of an Absorbable Surgical Hemostatic Agent: Thrombi-Gel® Versus Gelfoam-ThrombinCompletedNCT00652314Phase 4Results posted
• Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary EmbolismCompletedNCT00643201Phase 3Results posted
• Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary EmbolismCompletedNCT00633893Phase 3Results posted
• Identification and Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis in Children With CancerTerminatedNCT00633061Phase 2Results posted
• Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVTCompletedNCT00585182Phase 4Results posted
• Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 4CompletedNCT00574340Early Phase 1Results posted
• Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic MalignancyTerminatedNCT00539942Phase 3Results posted
• Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill PatientsTerminatedNCT00521885Not applicableResults posted

← Thrombosis overview